Benefit of vaccination with the Intanza® 15 µg intradermal influenza vaccine on subjects aged 60 and over

Abstract

Report of the Technical Vaccination Committee (Comité technique des vaccinations - CTV) on the benefit of vaccination with the Intanza® 15 µg intradermal influenza vaccine on subjects aged 60 and over (May 2010). Source: http://www.hcsp.fr/docspdf/avisrapports/hcspr20100528_intanza15.pdf

Recommendation Europe France health policy Influenza